Overview

Price chart · mood · technical indicators

IHE

ISHARES U.S. PHARMACEUTICALS ETF etf

$89.9437.31%Current Market Mood:Strong Bullish

Market Mood

Price Range (1Y)

$64.46$93.05

Current: $89.94

Composition

Holdings as published by the issuer · refreshed weekly

Net assets$946.2M

Expense ratio0.38%

Dividend yield1.25%

InceptionMay 1, 2006

Top holdings (59 total)

#	Name	Weight
1	LLY Eli Lilly and co	23.35%
2	JNJ Johnson & Johnson	21.14%
3	VTRS Viatris inc	5.13%
4	RPRX Royalty Pharma plc Class a	5.12%
5	MRK Merck & co inc	4.62%
6	BMY Bristol-myers Squibb co	4.35%
7	PFE Pfizer inc	4.16%
8	JAZZ Jazz Pharmaceuticals plc	3.90%
9	ZTS Zoetis inc Class a	2.98%
10	ELAN Elanco Animal Health inc	2.89%

Page 1 of 6 · 59 total

Sector breakdown

#	Name	Weight
1	Healthcare	99.50%
2	Information Technology	0.00%
3	Communication Services	0.00%
4	Consumer Discretionary	0.00%
5	Consumer Staples	0.00%
6	Industrials	0.00%
7	Materials	0.00%
8	Utilities	0.00%
9	Energy	0.00%
10	Financials	0.00%

Page 1 of 2 · 11 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer

Overview

IHE

Composition

Top holdings (59 total)

Sector breakdown

News & Sentiment

Eli Lilly and Jumps 5.5% Amid Sector-Wide Rally

Goldman Sachs, Johnson & Johnson, MetLife Named Among Newsweek’s World’s Greenest Companies 2026

Merck & Co Inc Stock (MRK) Moved Up by 3.33% on Jun 4: What Signal Does It Send?

Why Is Pfizer (PFE) Down 4.5% Since Last Earnings Report?

Eli Lilly and Co Stock (LLY) Moved Up by 3.56% on Jun 4: What Signal Does It Send?

Johnson And Johnson Autoimmune Trial Data And What It Means For JNJ

TD Asset Management Inc Grows Position in Merck & Co., Inc. $MRK

Canaccord initiates Pulse Biosciences stock with buy on ablation tech By Investing.com

WCG Wealth Advisors LLC Acquires 22,434 Shares of Johnson & Johnson $JNJ

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity

CereVasc closes $85M Series C to support eShunt system with investment from J&J, Medtronic

Leerink raises Nanobiotix stock price target on cancer drug data By Investing.com

Deutsche Bank raises Spyre stock price target on competitor setback

Deutsche Bank raises Spyre stock price target on competitor setback

Cibc World Market Inc. Purchases 320,143 Shares of Merck & Co., Inc. $MRK

CVS Health Corporation $CVS Shares Acquired by Bank of New York Mellon Corp

Exelixis director Jack Wyszomierski sells $198,408 in shares

Moderna (MRNA) Climbs 7.5% Ahead of Next Week’s Key Updates

Moderna rallies on renewed optimism around its Merck-partnered melanoma vaccine program

IHE

IHE Market Analysis

Overview

IHE

Composition

Top holdings (59 total)

Sector breakdown

News & Sentiment

Eli Lilly and Jumps 5.5% Amid Sector-Wide Rally

Goldman Sachs, Johnson & Johnson, MetLife Named Among Newsweek’s World’s Greenest Companies 2026

Merck & Co Inc Stock (MRK) Moved Up by 3.33% on Jun 4: What Signal Does It Send?

Why Is Pfizer (PFE) Down 4.5% Since Last Earnings Report?

Eli Lilly and Co Stock (LLY) Moved Up by 3.56% on Jun 4: What Signal Does It Send?

Johnson And Johnson Autoimmune Trial Data And What It Means For JNJ

TD Asset Management Inc Grows Position in Merck & Co., Inc. $MRK

Canaccord initiates Pulse Biosciences stock with buy on ablation tech By Investing.com

WCG Wealth Advisors LLC Acquires 22,434 Shares of Johnson & Johnson $JNJ

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity

CereVasc closes $85M Series C to support eShunt system with investment from J&J, Medtronic

Leerink raises Nanobiotix stock price target on cancer drug data By Investing.com

Deutsche Bank raises Spyre stock price target on competitor setback

Deutsche Bank raises Spyre stock price target on competitor setback

Cibc World Market Inc. Purchases 320,143 Shares of Merck & Co., Inc. $MRK

CVS Health Corporation $CVS Shares Acquired by Bank of New York Mellon Corp

Exelixis director Jack Wyszomierski sells $198,408 in shares

Moderna (MRNA) Climbs 7.5% Ahead of Next Week’s Key Updates

Moderna rallies on renewed optimism around its Merck-partnered melanoma vaccine program

IHE